Paul Tudor Jones Novo Nordisk A S Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Novo Nordisk A S stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 122,042 shares of NVO stock, worth $10.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

122,042

Previous 14,227 757.82%

Holding current value

$10.9 Million

Previous $1.69 Million 519.72%

% of portfolio

0.04%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $9.16 Million - $12.9 Million	107,815 Added 757.82%	122,042 $10.5 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $1.69 Million - $2.07 Million	14,227 New	14,227 $1.69 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $16.5 Million - $21.9 Million	-161,191 Reduced 75.85%	51,315 $6.59 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $4.52 Million - $5.43 Million	51,499 Added 31.99%	212,506 $22 Million
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $12.2 Million - $26.8 Million	134,553 Added 508.63%	161,007 $14.6 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $352,202 - $389,843	2,258 Added 9.33%	26,454 $4.28 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $3.2 Million - $3.85 Million	24,196 New	24,196 $3.85 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $1.24 Million - $1.46 Million	12,006 New	12,006 $1.34 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $409,733 - $495,288	-4,401 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $421,967 - $515,269	4,401 New	4,401 $493,000

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $201B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account